Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

This study has been completed.

Study NCT00255255 Information provided by AstraZeneca

First Received: November 17, 2005 Last Updated: January 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2007
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)